Search Results - "BARNES, David S"

Ohio solid organ transplantation consortium criteria for liver transplantation in patients with alcoholic liver disease by Hajifathalian, Kaveh, Humberson, Annette, Hanouneh, Mohamad A, Barnes, David S, Arora, Zubin, Zein, Nizar N, Eghtesad, Bijan, Kelly, Dympna, Hanouneh, Ibrahim A

“…AIM To evaluate risk of recidivism on a case-by-case basis.METHODS From our center’s liver transplant program,we selected patients with alcoholic liver disease…”
Get full text

Cargo, "Infection," and the Logic of Quarantine in the Nineteenth Century by BARNES, DAVID S.

“…In the nineteenth century, maritime quarantine officials often paid more attention to ships' cargo than they did to the health of passengers or crew members…”
Get full text

Feverish Bodies, Enlightened Minds: Science and the Yellow Fever Controversy in the Early American Republic by Thomas A. Apel (review) by Barnes, David S

Get full text

Prevalence of celiac disease in cirrhosis and outcome of cirrhosis on a gluten free diet: A prospective study by Wakim-Fleming, Jamile, Pagadala, Mangesh R, McCullough, Arthur J, Lopez, Rocio, Bennett, Ana E, Barnes, David S, Carey, William D

“…Background & Aims Current consensus suggests CD to be a multi-systemic disease that could affect any organ system including the liver. It remains…”
Get full text

Predicting outcome after cardiac surgery in patients with cirrhosis: a comparison of Child-Pugh and MELD scores by Suman, Amitabh, Barnes, David S, Zein, Nizar N, Levinthal, Gavin N, Connor, Jason T, Carey, William D

“…This study aims to quantify the risk of cardiac surgery in patients with cirrhosis. Records of all adult patients with cirrhosis undergoing cardiac surgery…”
Get more information

Reversal of fibrosis in patients with nonalcoholic steatohepatosis after gastric bypass surgery by Parker, Brian M, Wu, Jiang, You, Jing, Barnes, David S, Yerian, Lisa, Kirwan, John P, Schauer, Philip R, Sessler, Daniel I

“…Roux-en-Y gastric bypass (RYGB) improves the pathophysiology that contributes to obesity-related nonalcoholic steatohepatitis (NASH). Whether obesity-related…”
Get full text

229 The Stroop App Can Predict the Development of Overt Hepatic Encephalopathy in a Multi-Center Study by Bajaj, Jasmohan S, Allampati, Sanath, Duarte-Rojo, Andres, Patidar, Kavish, White, Melanie B, Hovermale, James, Heuman, Douglas M, Klair, Jagpal S, John, Binu, Gavis, Edith A, Barnes, David S, Unser, Ariel, Thacker, Leroy R

Get full text

Hepatic Failure Due to Cholestatic Hepatitis C in an Immunosuppressed Patient Treated With Elbasvir and Grazeprevir by Nassar, Amin H, Abdul-Jawad, Baraa M, Barnes, David S

“…Hepatitis C-induced cholestatic hepatitis is a well-known fatal complication of postorthotropic liver transplantation and prolonged immunosuppression. Recent…”
Get full text

NASH Patients With Ascites Frequently Have Normal Serum Albumin, but a Higher Mortality When Low Albumin Occurs by Sourianarayanane, Achuthan, O'Shea, Robert, Barnes, David S, McCullough, Arthur J

Get full text

Su1692 Post Liver Transplantation Sarcopenia in Cirrhosis: Mechanisms and Prospective Evaluation by Tsien, Cynthia, Garber, Ari, Narayanan, Arvind, Shah, Shetal, Barnes, David S, Eghtesad, Bijan, Fung, John J, McCullough, Arthur J, Dasarathy, Srinivasan

Get full text

Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosis by COMBES, Burton, EMERSON, Scott S, BENNER, Kent G, KOWDLEY, Kris V, CARITHERS, Robert L, ROSOFF, Leonard JR, GARCIA-TSAO, Guadalupe, BOYER, James L, BOYER, Thomas D, MARTINEZ, Enrique J, BASS, Nathan M, LAKE, John R, FLYE, Nancy L, BARNES, David S, BONACINI, Maurizio, LINDSAY, Karen L, MILLS, A. Scott, MARKIN, Rodney S, RUBIN, Raphael, WEST, A. Brian, WHEELER, Donald E, CONTOS, Melissa J, HOFMANN, Alan F, MUNOZ, Santiago J, LUKETIC, Velimir A, MAYO, Marlyn J, MCCASHLAND, Timothy M, ZETTERMAN, Rowen K, PETERS, Marion G, DI BISCEGLIE, Adrian M

“…This placebo-controlled, randomized, multicenter trial compared the effects of MTX plus UDCA to UDCA alone on the course of primary biliary cirrhosis (PBC)…”
Get full text

High prevalence of normal serum albumin in NASH patients with ascites: A retrospective analysis by Sourianarayanane, Achuthan, O'Shea, Robert S, Barnes, David S, McCullough, Arthur J

“…Summary Background Ascites usually occurs in the setting of end-stage liver disease and low serum albumin and is associated with increased mortality. However,…”
Get full text

Obesity and Non-Alcoholic Fatty Liver Disease in Chronic Hepatitis C by Younossi, Zobair M, McCullough, Arthur J, Ong, Janus P, Barnes, David S, Post, Anthony, Tavill, Anthony, Bringman, Diane, Martin, Lisa M, Assmann, Jennifer, Gramlich, Terry, Mullen, Kevin D, O’Shea, Robert, Carey, William D, Ferguson, Roy

“…BACKGROUNDSuperimposed non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) may affect HCV-related fibrosis. We performed a study…”
Get full text

797 Comparison of Adenoma Detection by Inspection During Both Insertion and Withdrawal Phases Versus Only Withdrawal Phase of Colonoscopy: A Randomized Controlled Trial by Sanaka, Madhusudhan R, Parsi, Mansour A, Burke, Carol A, Church, James M, Barnes, David S, Rizk, Maged K, Zein, Nizar N, Joseph, Rajesh, Thota, Prashanthi N, Lopez, Rocio, Kiran, Pokala R

Get full text

Beneficial effect of midodrine in hypotensive cirrhotic patients with refractory ascites by Sourianarayanane, Achuthan, Barnes, David S, McCullough, Arthur J

Get full text

Immunogenicity of hepatitis A vaccine in decompensated liver disease by Dumot, John A, Barnes, David S, Younossi, Zobair, Gordon, Steven M, Avery, Robin K, Domen, Ronald E, Henderson, Michael J, Carey, William D

“…Hepatitis A can cause decompensation and death in patients with previous liver injury. The hepatitis A vaccine is recommended for patients with chronic liver…”
Get full text

Pegylated interferon α-2b, ribavirin and amantadine for chronic hepatitis C by YOUNOSSI, Zobair M, MCCULLOUGH, Arthur C, MULLEN, Kevin D, CAREY, William D, TAVILL, Anthony S, FERGUSON, Roy, GRAMLICH, Terry, BARNES, David S, POST, Anthony, ONG, Janus P, O'SHEA, Robert, MARTIN, Lisa M, BRINGMAN, Diane, FARMER, Denise, LEVINTHAL, Gavin

Get full text

A randomized, double-blind controlled trial of interferon alpha-2b and ribavirin vs. interferon alpha-2b and amantadine for treatment of chronic hepatitis C non-responder to interferon monotherapy by Younossi, Zobair M, Mullen, Kevin D, Zakko, Wisam, Hodnick, Sandra, Brand, Edward, Barnes, David S, Carey, William D, McCullough, Arthur C, Easley, Kirk, Boparai, Navdeep, Gramlich, Terry

“…Background/Aims : Interferon-based regimens (alone or with ribavairin) are standard therapies for chronic hepatitis C. The aim of this study was to compare a…”
Get full text

Triple Combination of Interferon Alpha-2b, Ribavirin, and Amantadine for Treatment of Chronic Hepatitis C by Younossi, Zobair M, Mullen, Kevin D, Hodnick, Sandra, Barnes, David S, Carey, William D, McCullough, Arthur C, Easley, Kirk, Gramlich, Terry, Liebermann, Belinda Yen

“…Retreatment of interferon-resistant chronic hepatitis C represents a significant clinical challenge. In an open-label, pilot study, the safety and efficacy of…”
Get full text

Pretreatment With Methylprednisolone to Prevent Ercp-Induced Pancreatitis: A Randomized, Multicenter, Placebo-Controlled Clinical Trial by DUMOT, J. A, CONWELL, D. L, PONSKY, J. L, ZUCCARO, G, O'CONNOR, J. B, FERGUSON, D. R, VARGO, J. J, BARNES, D. S, SHAY, S. S, STERLING, M. J, HORTH, K. S, ISSA, K

“…Pancreatitis remains the major complication of endoscopic retrograde cholangiopancreatography (ERCP). Uncontrolled data suggest a lower incidence of…”
Get full text